1. Is it bye-bye Bextra in the US, EU and Canada?

   News item 21 January 2013 Pages: 2 - 2

2. ADR reports up 11.2% in Canada

   News item 21 January 2013 Pages: 3 - 3

3. Health Canada reports adverse reactions with bee products

   News item 21 January 2013 Pages: 3 - 3

4. Hylan-G-F-20: reports of joint inflammation and pain on injection

   News item 21 January 2013 Pages: 3 - 3

5. Iodixanol cost effective vs iohexol among high-risk patients

   Clinical study 21 January 2013 Pages: 3 - 3

6. Off-label atypical antipsychotic use could be deadly

   Media release 21 January 2013 Pages: 3 - 3

7. Antipsychotics are not the only drugs associated with movement disorders

   Clinical study 21 January 2013 Pages: 5 - 5

8. Aripiprazole associated with dyskinesias

   Clinical study 21 January 2013 Pages: 5 - 5

9. Olanzapine lower risk of tardive dyskinesia than conventional antipsychotics

   Clinical study 21 January 2013 Pages: 5 - 5

10. Physician preference more important than patient risk

    Clinical study 21 January 2013 Pages: 5 - 5

11. Rasagiline appears to be relatively well tolerated

    Clinical study 21 January 2013 Pages: 5 - 5

12. Risk of endometrial cancer increases with prolonged tamoxifen use

    Clinical study 21 January 2013 Pages: 5 - 5

13. Allopurinol/carbamazepine/dipyrone

    Case reports 21 January 2013 Pages: 6 - 6

14. Amphotericin B overdose

    Case report 21 January 2013 Pages: 6 - 6

15. Atorvastatin interaction

    Case report 21 January 2013 Pages: 6 - 7

16. Benzalkonium chloride/triclosan

    Case report 21 January 2013 Pages: 7 - 7

17. Ciclosporin

    Case report 21 January 2013 Pages: 7 - 7

18. Citalopram interaction

    Case report 21 January 2013 Pages: 7 - 8

19. Clozapine

    Case report 21 January 2013 Pages: 8 - 8

20. Cyclophosphamide/doxorubicin

    Case report 21 January 2013 Pages: 8 - 8

21. Dipotassium clorazepate

    Case report 21 January 2013 Pages: 8 - 9

22. Dorzolamide

    Case reports 21 January 2013 Pages: 9 - 9

23. Enoxaparin sodium/warfarin

    Case report 21 January 2013 Pages: 9 - 9

24. Etanercept

    Case reports 21 January 2013 Pages: 9 - 10

25. Etanercept

    Case report 21 January 2013 Pages: 10 - 10

26. Felodipine

    Case report 21 January 2013 Pages: 10 - 10

27. Herbal medicines

    Case report 21 January 2013 Pages: 10 - 10

28. HMG-CoA reductase inhibitors

    Case reports 21 January 2013 Pages: 10 - 11

29. Interferon-α

    Case report 21 January 2013 Pages: 11 - 11

30. Lamivudine

    Case report 21 January 2013 Pages: 11 - 11

31. Levetiracetam

    Case report 21 January 2013 Pages: 11 - 11

32. Levothyroxine sodium

    Case report 21 January 2013 Pages: 11 - 12

33. Lithium/minocycline

    Case report 21 January 2013 Pages: 12 - 12

34. Magnesium sulfate

    Case report 21 January 2013 Pages: 12 - 12

35. Methotrexate

    Case reports 21 January 2013 Pages: 12 - 13

36. Methylphenidate

    Case report 21 January 2013 Pages: 13 - 13

37. Neuropsychotherapeutics/verapamil overdose

    Case report 21 January 2013 Pages: 13 - 13

38. Nortriptyline interaction

    Case report 21 January 2013 Pages: 13 - 13

39. Olanzapine

    Case report 21 January 2013 Pages: 14 - 14

40. Paclitaxel interaction

    Case report 21 January 2013 Pages: 14 - 14

41. Paracetamol overdose

    Case report 21 January 2013 Pages: 14 - 14

42. Peginterferon-α-2a/ribavirin

    Case report 21 January 2013 Pages: 14 - 15

43. Permethrin

    Case report 21 January 2013 Pages: 15 - 15

44. Quetiapine interaction

    Case report 21 January 2013 Pages: 15 - 15

45. Quetiapine/risperidone overdose

    Case report 21 January 2013 Pages: 15 - 15

46. Quetiapine/risperidone/valproate semisodium

    Case report 21 January 2013 Pages: 16 - 16

47. Rituximab

    Case report 21 January 2013 Pages: 16 - 16

48. Sirolimus interaction

    Case report 21 January 2013 Pages: 17 - 17

49. Tacrolimus interaction

    Case report 21 January 2013 Pages: 17 - 17

50. Vancomycin

    Case report 21 January 2013 Pages: 17 - 18